Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude.
Introduced
Jan 28, 2025
Last Action
Mar 13, 2026
Session
IL 104th
Sponsors
1 primary · 1 co
Rule 2-10 Committee Deadline Established As March 27, 2026
Senate Committee Amendment No. 1 Assignments Refers to Insurance
Senate Committee Amendment No. 1 Referred to Assignments
Senate Committee Amendment No. 1 Filed with Secretary by Sen. Graciela Guzmán
Re-assigned to Insurance
Rule 3-9(a) / Re-referred to Assignments
Rule 2-10 Committee/3rd Reading Deadline Established As May 9, 2025
Rule 2-10 Committee Deadline Established As April 11, 2025
Rule 2-10 Committee Deadline Established As April 4, 2025
Assigned to Insurance
Added as Co-Sponsor Sen. Rachel Ventura
Filed with Secretary by Sen. Graciela Guzmán
Referred to Assignments
First Reading
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Rule 2-10 Committee Deadline Established As March 27, 2026